FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:798-799 March 11, 1999 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by El-Serag, H. B. PubMed Citation

Primary hepatocellular carcinoma, one of the most common tumors in the world today, is occurring with increasing frequency in the United States, as shown in the study by El-Serag and Mason in this issue of the Journal.¹ The most likely reason for this rising incidence is the spread of hepatitis virus infection in the population. Indeed, there is no better example of a tumor that is associated with persistent viral infection than hepatocellular carcinoma. Two viruses cause almost all these tumors: hepatitis B virus (HBV) and hepatitis C virus (HCV).

The global distribution of hepatocellular carcinoma correlates with the geographic . . . [Full Text of this Article]

References

Related Letters:

The Rising Incidence of Hepatocellular Carcinoma
Kaczynski J., Odén A., Watson R. W., El-Serag H. B., Mason A. C., Ince N., Wands J. R.
Extract | Full Text  
N Engl J Med 1999; 341:451-452, Aug 5, 1999. Correspondence

This article has been cited by other articles:

• Frieden, T. R., Myers, J. E., Krauskopf, M. S., Farley, T. A. (2008). A Public Health Approach to Winning the War Against Cancer. The Oncologist 13: 1306-1313 [Abstract] [Full Text]  
• Huynh, H., Soo, K. C., Chow, P. K.H., Tran, E. (2007). Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma. Molecular Cancer Therapeutics 6: 138-146 [Abstract] [Full Text]  
• Huynh, H., Soo, K. C., Chow, P. K.H., Panasci, L., Tran, E. (2006). Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs.. Clin. Cancer Res. 12: 4306-4314 [Abstract] [Full Text]  
• Hertl, M., Cosimi, A. B. (2005). Liver Transplantation for Malignancy. The Oncologist 10: 269-281 [Abstract] [Full Text]  
• Huynh, H. (2004). Overexpression of tumour suppressor retinoblastoma 2 protein (pRb2/p130) in hepatocellular carcinoma. Carcinogenesis 25: 1485-1494 [Abstract] [Full Text]  
• Butterfield, L. H., Ribas, A., Meng, W. S., Dissette, V. B., Amarnani, S., Vu, H. T., Seja, E., Todd, K., Glaspy, J. A., McBride, W. H., Economou, J. S. (2003). T-Cell Responses to HLA-A*0201 Immunodominant Peptides Derived from {alpha}-Fetoprotein in Patients with Hepatocellular Cancer. Clin. Cancer Res. 9: 5902-5908 [Abstract] [Full Text]  
• Krinsky, G. A., Lee, V. S., Theise, N. D., Weinreb, J. C., Rofsky, N. M., Diflo, T., Teperman, L. W. (2001). Hepatocellular Carcinoma and Dysplastic Nodules in Patients with Cirrhosis: Prospective Diagnosis with MR Imaging and Explantation Correlation. Radiology 219: 445-454 [Abstract] [Full Text]  
• Pulling, L. C., Klinge, D. M., Belinsky, S. A. (2001). p16INK4a and {beta}-catenin alterations in rat liver tumors induced by NNK. Carcinogenesis 22: 461-466 [Abstract] [Full Text]  
• Feng, S.-L. Y., Guo, Y., Factor, V. M., Thorgeirsson, S. S., Bell, D. W., Testa, J. R., Peifley, K. A., Winkles, J. A. (2000). The Fn14 Immediate-Early Response Gene Is Induced During Liver Regeneration and Highly Expressed in Both Human and Murine Hepatocellular Carcinomas. Am. J. Pathol. 156: 1253-1261 [Abstract] [Full Text]  
• Kaczynski, J., Oden, A., Watson, R. W., El-Serag, H. B., Mason, A. C., Ince, N., Wands, J. R. (1999). The Rising Incidence of Hepatocellular Carcinoma. NEJM 341: 451-452 [Full Text]